We must strike a delicate balance with the policies we pass through this Committee to ensure they do not put a damper on this success or deter investment in biomedical research and innovation.
Michael Burgess: “We must strike a delicate balance with the policies we pass through this Committee to ensure they do not put a damper on…”
Editor's note · Context
Burgess calls for careful policy-making to support biomedical innovation.
Share
More from Michael Burgess
I never expected that CMMI was actually going to deliver the cost savings that was promised.
I urge all my fellow colleagues to join me in supporting H.R. 766 and ensuring that we continue to prioritize preventive healthcare initiatives for the betterment of all Americans, and I reserve the balance of my time.
This is a national emergency. This is something we have got to address and save Americans, 200 every day.
For the purpose of debate only, I yield the customary 30 minutes to the Congresswoman from Pennsylvania (Ms. Scanlon), pending which I yield myself such time as I may consume. During consideration of this resolution, all time yielded is…





